IntelGenx Technologies (IGXT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
IntelGenx Technologies Corp., a leader in pharmaceutical films, has announced restructuring under the CCAA to explore strategic alternatives, including a potential sale, recapitalization, or other transactions. The move follows a comprehensive review by the Board, seeking to maximize returns and sustain operations, while the company’s stock trading remains halted pending a TSX suitability review. Interim financing is expected to support IntelGenx through its strategic review and restructuring process.
For further insights into IGXT stock, check out TipRanks’ Stock Analysis page.